Preventing end stage renal disease in diabetic patients — genetic aspect (part I)
Open Access
- 1 March 2005
- journal article
- review article
- Published by SAGE Publications in Journal of the Renin-Angiotensin-Aldosterone System
- Vol. 6 (1), 1-14
- https://doi.org/10.3317/jraas.2005.001
Abstract
Diabetic nephropathy is a major cause of diabetes-related morbidity and mortality; however the clinical course of the disease and the renal prognosis is highly variable among individuals. The current review will discuss the genetic influence on the development of end stage renal disease (ESRD) in diabetic patients and potential improvements to the current treatment strategy to slow the loss of kidney function in these patients. In this first part, the growing evidence that glucose-induced activation of the intra-renal and systemic renin-angiotensin systems plays an essential role in processes leading to destruction of renal function is summarised. Genetic variations, especially the angiotensin-converting enzyme (ACE)/ID polymorphisms in the gene coding for ACE, are involved in activation of the renin-angiotensin system and seem to influence the clinical course of diabetic nephropathy during treatment with ACE inhibitors. In addition, this polymorphism may interact with other polymorphisms within the reninangiotensin system, leading to high risk of ESRD. As new genetic approaches and methods develop, further understanding of diabetic nephropathy will evolve and genotyping will help prevent ESRD in diabetic patients.Keywords
This publication has 162 references indexed in Scilit:
- A Gene-Expression Signature as a Predictor of Survival in Breast CancerNew England Journal of Medicine, 2002
- Role of uteroglobin G38A polymorphism in the progression of IgA nephropathy in Japanese patientsKidney International, 2002
- Initial sequencing and analysis of the human genomeNature, 2001
- Risk of advanced diabetic nephropathy in type 1 diabetes is associated with endothelial nitric oxide synthase gene polymorphismKidney International, 2000
- Contribution of genetic polymorphism in the renin-angiotensin system to the development of renal complications in insulin-dependent diabetes: Genetique de la Nephropathie Diabetique (GENEDIAB) study group.JCI Insight, 1997
- Molecular basis of human hypertension: Role of angiotensinogenCell, 1992
- An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels.JCI Insight, 1990
- Serial micropuncture analysis of glomerular function in two rat models of glomerular sclerosis.JCI Insight, 1988
- Impaired autoregulation of cerebral blood flow in long‐term Type I (insulin‐dependent) diabetic patients with nephropathy and retinopathyClinical Physiology and Functional Imaging, 1986
- Long-term antihypertensive treatment inhibiting progression of diabetic nephropathyBMJ, 1982